Guangzhou Baiyunshan Pharmaceutical Holdings A is a leading Chinese pharmaceutical group specializing in the research, development, and production of medicines. Its portfolio includes Western pharmaceuticals, traditional Chinese medicine, health-promoting consumer goods, and various medical products.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Guangzhou Baiyunshan Pharmaceutical Holdings A is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Guangzhou Baiyunshan Pharmaceutical Holdings A last reported quarterly earnings on 8/21/2026 (Q2 2026). Earnings per share (EPS) came in at 1.29 CNY.
Across its last 3 earnings reports, Guangzhou Baiyunshan Pharmaceutical Holdings A stock moved by ±1.4% on average the following day. The largest reaction was -2.8% on 08/21/2026; 0 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.